Dimensional Fund Advisors LP
- SEC CIK
- 0000354204
- Latest filing
- Aug 11, 2026
ELVN holding history
Enliven Therapeutics, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ELVN overviewAll 13F holders of ELVNFull Q2 2026 holdings
- Shares (Q2 2026)
- 671,412
- Value
- $34.1M
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 671,412 | $34.1M | <0.1% | −10,303−1.5% | Reduced | Holders |
| Q1 2026 | 681,715 | $26.7M | <0.1% | +282,822+70.9% | Added | Holders |
| Q4 2025 | 398,893 | $6.14M | <0.1% | +238,434+148.6% | Added | Holders |
| Q3 2025 | 160,459 | $3.28M | <0.1% | +113,608+242.5% | Added | Holders |
| Q2 2025 | 46,851 | $941.8K | <0.1% | +46,851 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −23,762−100.0% | Sold out | Holders |
| Q2 2023 | 23,762 | $485.0K | <0.1% | +13,847+139.7% | Added | Holders |
| Q1 2023 | 9,915 | $217.1K | <0.1% | −25,976−72.4% | Reduced | Holders |
| Q4 2022 | 35,891 | $147.0K | <0.1% | +7,626+27.0% | Added | Holders |
| Q3 2022 | 28,265 | $64.0K | <0.1% | +28,265 | New | Holders |